The AIM Study: Assessing the Impact of Margin Reduction
EPIC surveys and adverse events recorded and categorized using the CTCAE v3.0 will be
collected and summary statistics performed. The patient's individual tracking graphs will
be evaluated for motion type and frequency.
Observational
Observational Model: Cohort, Time Perspective: Prospective
Evaluate patient quality of life using Expanded Prostate Cancer Index Composite (EPIC) for evaluation of the QOL
2 year follow-up
No
Constantine Mantz, MD
Principal Investigator
21st Century Oncology
United States: Institutional Review Board
CMT-03-08
NCT00754000
July 2008
September 2009
Name | Location |
---|---|
21st Century Oncology - Scottsdale | Scottsdale, Arizona 85251 |
21st Century Oncology - Santa Monica | Santa Monica, California 90404 |
21st Century Oncology | Cape Coral, Florida 33990 |
21st Century Oncology - Plantation | Plantation, Florida 33324 |